Inotropic Therapy for Heart Failure

Jay N. Cohn

Research output: Contribution to journalEditorialpeer-review

22 Scopus citations


For those who have believed that the primary defect in chronic heart failure is a reduction in myocardial contractile force, the search for a potent, oral positive inotropic agent has been one of the most important efforts in cardiology. In recent years the search has focused on drugs that inhibit cardiac phosphodiesterase activity, since these drugs can increase myocardial levels of cyclic AMP and enhance the contractility of the failing ventricle. Early optimism about these drugs was based on their favorable and apparently sustained hemodynamic effects and on early reports of dramatic clinical improvement in patients with advanced heart failure…

Original languageEnglish (US)
Pages (from-to)729-731
Number of pages3
JournalNew England Journal of Medicine
Issue number11
StatePublished - Mar 16 1989


Dive into the research topics of 'Inotropic Therapy for Heart Failure'. Together they form a unique fingerprint.

Cite this